Heparin crisis rekindles concern about disease from pig transplants
From ANIMAL PEOPLE, March 2008:
DEERFIELD, Ill.; chang-zhau–Concern
about the possibility of pig diseases crossing
into humans through medical procedures using pig
byproducts rose worldwide after the drug maker
Baxter International on February 25, 2008
suspended sales of the blood-thinning product
heparin.
Baxter International, of Deerfield,
Illinois, reportedly distributes more than a
million doses of heparin annually, amounting to
about half of the U.S. supply.